Cargando…

Nanonutraceuticals: Anti-Cancer Activity and Improved Safety of Chemotherapy by Costunolide and Its Nanoformulation against Colon and Breast Cancer

Costunolide (COS) is a sesquiterpene lactone with anticancer properties. The present study investigated the anticancer effects of COS against the human colon (HCT116) and breast (MDA-MB-231-Luc) cancer cell lines. Inhibition of cell lines viability and IC50 of COS were assessed via an MTT assay. Fur...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Far, Ali H., Godugu, Kavitha, Salaheldin, Taher A., Darwish, Noureldien H. E., Saddiq, Amna A., Mousa, Shaker A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391151/ https://www.ncbi.nlm.nih.gov/pubmed/34440193 http://dx.doi.org/10.3390/biomedicines9080990

Ejemplares similares

Thymoquinone and Costunolide Induce Apoptosis of Both Proliferative and Doxorubicin-Induced-Senescent Colon and Breast Cancer Cells
por: El-Far, Ali H, et al.
Publicado: (2021)

Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases
por: El-Far, Ali H., et al.
Publicado: (2018)

Nanoformulated Bioactive Compounds Derived from Different Natural Products Combat Pancreatic Cancer Cell Proliferation
por: Mousa, Deena S, et al.
Publicado: (2020)

Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer
por: Godugu, Kavitha, et al.
Publicado: (2020)

Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
por: Salama, Lavinia, et al.
Publicado: (2020)

Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597
por: Godugu, Kavitha, et al.
Publicado: (2022)

Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone
por: El-Far, Ali H., et al.
Publicado: (2020)

Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression
por: Saddiq, Amna A., et al.
Publicado: (2022)

Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
por: Sudha, Thangirala, et al.
Publicado: (2020)

Novel Polyethylene Glycol-Conjugated Triazole Derivative with High Thyrointegrin αvβ3 Affinity in Acute Myeloid Leukemia Management
por: Sudha, Thangirala, et al.
Publicado: (2021)

Nanonutraceuticals Delivery
por: Dini, Luciana, et al.
Publicado: (2021)

Edible Green Solvent for Optimized Catechins Extraction from Green Tea Leaves: Anti-Hypercholesterolemia
por: Fujioka, Kazutoshi, et al.
Publicado: (2022)

Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1
por: Darwish, Noureldien H.E., et al.
Publicado: (2016)

Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines’ Progression
por: El-Far, Ali H., et al.
Publicado: (2022)

Potential of Nanonutraceuticals in Increasing Immunity
por: Jampilek, Josef, et al.
Publicado: (2020)

Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review
por: Chopra, Hitesh, et al.
Publicado: (2022)

Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α(v)β(3) Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780
por: Godugu, Kavitha, et al.
Publicado: (2022)

Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2019)

Nanonutraceuticals: The New Frontier of Supplementary Food
por: Paolino, Donatella, et al.
Publicado: (2021)

Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
por: Karakus, Ozlem Ozen, et al.
Publicado: (2021)

Correction: Karakus et al. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 2021, 9, 1713
por: Karakus, Ozlem Ozen, et al.
Publicado: (2022)

Current State-of-the-art Cutting-edge Technologies for Nanonutraceuticals in Cancer
por: Kutikuppala, L. V. Simhachalam, et al.
Publicado: (2023)

Anti-Cancer Activities of Thyrointegrin α(v)β(3) Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma
por: Godugu, Kavitha, et al.
Publicado: (2021)

An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics
por: Durazzo, Alessandra, et al.
Publicado: (2020)

Hepatitis C virus management: potential impact of nanotechnology
por: Elberry, Mostafa H., et al.
Publicado: (2017)

Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α(v)β(3) Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer
por: Sudha, Thangirala, et al.
Publicado: (2022)

Chemically-Modified Tetraiodothyroacetic Acid (Tetrac) Induces Cancer Cell Apoptosis and Facilitates Clearance of Apoptotic Debris (Efferocytosis)
por: Godugu, Kavitha, et al.
Publicado: (2021)

Anticancer Effects of the Corchorus olitorius Aqueous Extract and Its Bioactive Compounds on Human Cancer Cell Lines
por: Tosoc, John Paul Sese, et al.
Publicado: (2021)

Targeting Thyrointegrin αvβ3 Using Fluorobenzyl Polyethylene Glycol Conjugated Tetraiodothyroacetic Acid (NP751) in Acute Myeloid Leukemia
por: Darwish, Noureldien H. E., et al.
Publicado: (2022)

Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
por: Shiha, Gamal, et al.
Publicado: (2019)

Novel combined single dose anti-hepatitis C therapy: a pilot study
por: Shiha, Gamal, et al.
Publicado: (2021)

Pharmacokinetics of fluorobenzyl polyethylene glycol conjugated tetraiodothyroacetic acid (NP751), a novel anticancer thyrointegrin α(v)β(3) antagonist
por: Fujioka, Kazutoshi, et al.
Publicado: (2022)

Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
por: Mason, Darius L., et al.
Publicado: (2021)

Potential Anti-Cancer Activities and Mechanisms of Costunolide and Dehydrocostuslactone
por: Lin, Xuejing, et al.
Publicado: (2015)

Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme
por: Godugu, Kavitha, et al.
Publicado: (2022)

Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia
por: Abdulmalik, Osheiza, et al.
Publicado: (2021)

Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
por: Al-Gabri, Naif A, et al.
Publicado: (2021)

Prognostic value of some inflammatory markers in patients with lymphoma
por: Hamed Anber, Nahla, et al.
Publicado: (2019)

IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model
por: Salaheldin, Taher A, et al.
Publicado: (2019)

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
por: Sudha, Thangirala, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_60qmu0hocmbnjvdfc81lcp76gn